Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
Zaoqu Liu, Yuyuan Zhang, Chengcheng Shi, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma
Zhuolun Sun, Tao Wen, Xudong Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma
Mianli Bian, Rong Fan, Zhibin Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 1848-1866
Closed Access | Times Cited: 63
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 883-883
Open Access | Times Cited: 63
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence
Deng Wu, Jacquelyne Ka‐Li Sun, Hei‐Man Chow
PLoS Biology (2024) Vol. 22, Iss. 4, pp. e3002559-e3002559
Open Access | Times Cited: 13
Aberrant R-loop–mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis
Shichao Zhang, Yang Liu, Yichi Sun, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Integrated single-cell and bulk transcriptome analysis of R-loop score-based signature with regard to immune microenvironment, lipid metabolism and prognosis in HCC
Long Chen, Houzhi Yang, Xianfu Wei, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
Jing‐Xuan Xu, Yuangang Su, Yuanyuan Chen, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Junpeng Luo, Jing Wang, Jinhua Huang
Bioscience Reports (2021) Vol. 41, Iss. 10
Open Access | Times Cited: 52
Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
Zaoqu Liu, Taoyuan Lu, Jing Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
Yuyan Xu, Wei Liao, Qiong Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma
Zhuning Wang, Junqiao Yao, Tengyu Dong, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-40
Open Access | Times Cited: 29
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma
Henrike Salié, Lara Wischer, Antonio D’Alessio, et al.
Gut (2024), pp. gutjnl-332837
Closed Access | Times Cited: 8
High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma
Vicente Ramos‐Santillan, Masanori Oshi, Erek Nelson, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 2, pp. 257-267
Open Access | Times Cited: 7
PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
Tiantian Wu, Caijin Tang, Renchuan Tao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
Long Liu, Zaoqu Liu, Jie Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
Ning Kang, Xiao‐Li Xie, Xue Zhou, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects
Xuan-Yu Gu, Jinlong Huo, Yu Zhiyong, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 9-25
Open Access | Times Cited: 6
Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma
Zaoqu Liu, Long Liu, Chunguang Guo, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108340-108340
Closed Access | Times Cited: 30
The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
Tao Wang, Yi Yang, Ting Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma
Ye Nie, Hanlu Fan, Jianhui Li, et al.
The FASEB Journal (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 20
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
Zaoqu Liu, Siyuan Weng, Hui Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
Alice Boilève, Marc Hilmi, Matthieu Delaye, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2708-2708
Open Access | Times Cited: 24
Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis
Hui Xu, Zaoqu Liu, Siyuan Weng, et al.
Molecular Oncology (2022) Vol. 16, Iss. 22, pp. 4023-4042
Open Access | Times Cited: 19
Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
Lin Ding, Qian Yu, Shuo Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top